arrow
C

Chandan Kumar-Sinha

university of michigan
H指数:57
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets

整合蛋白质组学和代谢组学分析急性髓系白血病以识别分子亚型及相关治疗靶点

2026-06-120
OA
Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas

MCOLN3中的体细胞突变与醛固酮分泌腺瘤相关

2025-10-012
PRE
Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma

染色体不稳定性会破坏高危神经母细胞瘤中对于抗GD2免疫治疗效果所必需的发育表型。

2025-09-260
OAAI
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures

不同种族和暴露因素下肺腺癌的整合分析

2025-07-310
OAAI
Comprehensive proteogenomic characterization of rare kidney tumors

罕见肾肿瘤的综合蛋白质基因组学特征

2024-05-013
OAAI
Proteogenomic and metabolomic characterization of acute myeloid leukemia
2024-03-220
PRE
Genome instability in renal tumors
2024-03-220
PRE
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
2023-10-1814
OAAI
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism
2023-09-1413
PRE
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2023-08-1151
OAAI
CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS
2023-06-120
OAAI
Clinical response to the PDGFRα inhibitor avapritinib in high-grade glioma patients
2023-04-041
PRE
Comprehensive proteogenomic characterization of rare kidney tumors
2023-04-041
PRE
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
2022-06-018
OAAI